XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Loss per Share (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2024

Dec. 31, 2023

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities Excluded from Diluted Income (Loss) per Share

The following were excluded from the diluted loss per share calculation for the periods presented because their effect would be anti-dilutive:

		As of March 31,
		2024				2023
Outstanding stock options			303,133				134,283
Preferred stock			28,190				28,190
Outstanding warrants			142,733				142,733
Total			474,056				305,206

The following were excluded from the diluted loss per share calculation for the periods presented because their effect would be anti-dilutive:

		For the Year Ended December 31,
		2023				2022
Outstanding stock options			140,109				78,334
Preferred stock			28,190				28,190
Outstanding warrants			142,733				142,758
Total			311,032				249,282

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration